Merus N V Revenue per Employee (MRUS), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Merus N v   (NASDAQ: MRUS)
 

Merus N V 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 3.21% in the third quarter 2025, year on year to cumulative value of $57 million, Merus N V 's revenue per employee grew on a trailing twelve months basis to $ 539,105, this marks a new company high.
Within the Healthcare sector Employees of 58 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 617, from total ranking in previous quarter at 752. Merus N V has 105 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MRUS Revenue per Employee (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter
Y / Y Revenue Change 3.21 % 20.4 % 235.76 % 2.25 % 6.7 %
Sales per Employee (TTM) $ 539,105 535,505 521,257 344,124 342,210
MRUS's Total Ranking # 617 # 752 # 1329 # 1153 # 1619
Seq. Revenue Change 37.63 % -66.67 % 189.8 % -22.36 % 60.56 %

MRUS Company Profile >> Back to MRUS Efficiency Comparisons >> Compare MRUS Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 32
Healthcare Sector # 59
Overall Market # 617

Revenue per Employee Statistics
High Average Low
$ 539,105 $ 415,500 $ 285,171
(Sep 30 2025)   (Dec 31 2020)



Financial Statements
Merus N V 's Revenue MRQ $ 12 Millions Visit MRUS's Income Statement
Merus N V 's Revenues TTM $ 57 Millions Visit MRUS's aggregate revenue growth
What are MRUS's Sales? Visit MRUS's Sales by Segment




Other Ratios
Merus N V 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
MRUS's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for MRUS's Competitors
Revenue per Employee for MRUS's Suppliers
Revenue per Employee for MRUS's Customers

You may also want to know
MRUS's Sales Growth Rates MRUS's Pe Price to earnings ratio MRUS's Receivables Turnover Ratio MRUS's Stock Quote
MRUS's Net Income Growth Rates MRUS's Ps Price to Sales ratio MRUS's Sales per Employee MRUS's Asset Turnover Ratio
MRUS's Net Margin MRUS's Pb Price to Book ratio MRUS's Financial Strength Ratios MRUS's Dividend Payout Ratio
Date modified: 2026-06-23T19:22:37+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2025Number of Employees Sep 30 2025
Marker Therapeutics inc   938,997.80 $ 4.695  Million 5 
Sanara Medtech Inc   935,263.60 $ 101.008  Million 108 
Regeneron Pharmaceuticals Inc   924,581.44 $ 14,247.800  Million 15,410 
Hims and Hers Health Inc   904,784.60 $ 2,209.484  Million 2,442 
Arcutis Biotherapeutics Inc   898,104.52 $ 317.929  Million 354 
Theravance Biopharma inc   892,522.22 $ 80.327  Million 90 
Xtant Medical Holdings Inc   884,397.35 $ 133.544  Million 151 
Arcturus Therapeutics Holdings Inc   879,279.28 $ 97.600  Million 111 
Travere Therapeutics Inc   876,915.49 $ 435.827  Million 497 
Emergent Biosolutions Inc   876,555.56 $ 788.900  Million 900 
Ars Pharmaceuticals Inc   875,901.84 $ 142.772  Million 163 
Lexicon Pharmaceuticals Inc   874,864.20 $ 70.864  Million 81 
Pacira Biosciences inc   864,645.36 $ 716.791  Million 829 
Merck and Co Inc   856,466.67 $ 64,235.000  Million 75,000 
Evolus Inc   852,583.83 $ 284.763  Million 334 
Ani Pharmaceuticals Inc  852,453.61 $ 826.880  Million 970 
Carlisle Companies Incorporated  850,016.95 $ 5,015.100  Million 5,900 
Pfizer Inc  837,133.33 $ 62,785.000  Million 75,000 
Ardelyx inc   814,384.46 $ 398.234  Million 489 
Madrigal Pharmaceuticals Inc   809,442.62 $ 740.640  Million 915 
Alphatec Holdings Inc   798,450.16 $ 728.985  Million 913 
Elutia Inc   795,846.15 $ 20.692  Million 26 
Masimo Corp  779,363.64 $ 1,714.600  Million 2,200 
Fortress Biotech Inc   779,307.69 $ 60.786  Million 78 
Sutro Biopharma Inc   771,138.69 $ 105.646  Million 137 
Arbutus Biopharma Corp  768,736.84 $ 14.606  Million 19 
X4 Pharmaceuticals Inc  755,088.89 $ 33.979  Million 45 
Adma Biologics Inc   751,930.45 $ 486.499  Million 647 
Day One Biopharmaceuticals Inc   750,966.29 $ 133.672  Million 178 
Sanuwave Health Inc   750,600.00 $ 41.283  Million 55 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.